Elvanse Dosage Guide UK: Starting Dose, Titration and Maximum Dose Explained
If you have recently been prescribed Elvanse (lisdexamfetamine) for adult ADHD in the UK, one of the most common sources of confusion is dosing: what you should start on, how increases are supposed to work, and what the maximum dose actually is. This guide walks through the UK‑licensed dosing framework for Elvanse in adults, explains how titration typically unfolds week by week, and sets out the maximum recommended dose, side‑effect monitoring, and practical issues such as Schedule 2 status and costs. It also covers what to do if you are diagnosed but have no prescriber willing to continue your medication.
This is information only, not a recommendation. Do not change your dose or schedule without advice from your prescriber.
What Elvanse is and how it works
Elvanse contains lisdexamfetamine dimesylate, a prodrug that is inactive until your body converts it into dexamfetamine. After you swallow the capsule, lisdexamfetamine is absorbed from the gut and then broken down mainly by red blood cells into dexamfetamine, which is the active medicine. Dexamfetamine increases levels of dopamine and noradrenaline in the brain, helping to improve attention, reduce impulsivity, and calm hyperactivity in people with ADHD. Because it is a prodrug with modified release, the effect comes on more smoothly and usually lasts most of the day after a single morning dose.
UK licensed indications: Elvanse vs Elvanse Adult
In the UK, “Elvanse” and “Elvanse Adult” are separate products with different licensed indications. They must not be treated as the same.
Elvanse (standard range): Licensed for children aged 6 years and over when response to previous methylphenidate treatment is considered clinically inadequate, and for adults with pre‑existing symptoms of ADHD in childhood.
Elvanse Adult: Licensed specifically for adults with ADHD as part of a comprehensive treatment programme.
Recent industry consolidation has moved many adults onto the single Elvanse brand in practice, but the underlying licensing distinction still matters for prescribing and shared‑care discussions. If you are unsure which product you have been prescribed, check the name and strength on your box and ask your prescriber or pharmacist to explain which licence applies to you.
Adult starting dose: what the SmPC and UK guidance say
For adults, the Summary of Product Characteristics (SmPC) for Elvanse Adult states:
Recommended starting dose: 30 mg once daily in the morning.
Lower start if needed: When, in the clinician’s judgement, a lower initial dose is appropriate, treatment may begin at 20 mg once daily in the morning.
Shared‑care protocols and local formularies in England and Scotland echo this: adults typically start at 30 mg once daily, with the option to use 20 mg if clinically appropriate (for example, if there are concerns about tolerability, comorbidities, or concomitant medicines).
You should never decide your own starting dose. Your specialist will choose between 20 mg and 30 mg based on your history, other conditions, and current medicines.
Titration explained: week by week (high‑level overview)
Titration is the process of starting low and increasing the dose gradually to find the lowest dose that gives clear benefit with tolerable side effects. NICE NG87 emphasises that dose should be titrated against symptoms and adverse effects, with regular monitoring and slower titration if certain comorbidities are present.
Typical adult titration pattern for Elvanse
While individual plans vary, UK SmPCs and shared‑care protocols describe a common pattern:
Week 1: Start at 30 mg once daily in the morning (or 20 mg if your clinician has chosen a lower start).
Week 2 onwards: If needed and tolerated, the dose may be increased in increments of 10–20 mg at approximately weekly intervals. Many UK protocols describe 20 mg weekly steps for adults once the starting dose is established.
Target/maintenance: The aim is to reach the lowest dose that gives meaningful improvement in ADHD symptoms and functioning with side effects you can live with.
Maximum recommended dose: 70 mg once daily. Doses above 70 mg/day have not been studied in adults and are not recommended.
NICE guidance stresses that during titration, symptoms, impairment, and adverse effects should be recorded at baseline and at each dose change, with progress reviewed regularly (for example, by weekly telephone contact) with a specialist. Monitoring should be more frequent and titration slower if you have neurodevelopmental disorders, mental health conditions, or physical health problems such as cardiac disease.
What commonly goes wrong during titration
Increasing too quickly: Going up more often than weekly can make side effects feel overwhelming and obscure what dose actually works.
Ignoring sleep and appetite: Insomnia and decreased appetite are very common early on; if not managed (timing, food, sleep hygiene), they can derail titration.
Expecting immediate perfection: Benefits often build over days to weeks; some people feel “different” before they feel “better”.
Stopping abruptly due to side effects: Many early side effects settle or improve with dose adjustment; stopping without speaking to your prescriber can lose momentum and delay finding a workable regimen.
If titration feels stuck, the usual next step is a structured review with your specialist to adjust dose, timing, or consider switching to another first‑line option (for example, methylphenidate) as per NICE.
Maximum dose: what “70 mg/day” means in practice
The SmPC for Elvanse Adult clearly states:
Maximum recommended dose: 70 mg once daily; higher doses have not been studied.
In practice, this means:
Your specialist should not routinely exceed 70 mg/day in adults.
If you are on 70 mg and still have significant impairment, the conversation usually shifts to whether the diagnosis is correct, whether there are comorbidities undermining response, or whether a different medicine (for example, methylphenidate or a non‑stimulant) might be more appropriate, rather than simply going higher.
Any change above your current dose must be directed by your specialist; do not adjust your own dose.
Side effects and monitoring you should expect
Lisdexamfetamine is a Schedule 2 controlled drug and requires careful monitoring of cardiovascular and psychiatric status, weight, and side effects.
Common side effects in adults (selected)
Based on the SmPC and UK shared‑care guidance, very common and common side effects in adults include:
Very common: decreased appetite, weight decreased, insomnia, headache.
Common: dry mouth, diarrhoea, nausea, vomiting, tachycardia (fast heart rate), irritability, fatigue.
Uncommon: agitation, dysphoria, bruxism (teeth grinding), mania, hallucinations, dyskinesia, mydriasis (pupil dilation), blood pressure increased.
If you develop chest pain, fainting, severe mood changes, hallucinations, signs of an allergic reaction, or any symptom that feels dangerous, seek urgent medical help and contact your prescriber.
Monitoring schedule (typical UK practice)
NICE NG87 and shared‑care protocols recommend:
Before starting and after each dose change: record blood pressure, pulse, weight, and psychiatric symptoms.
Once stable: monitor at least every 6 months (blood pressure, pulse, weight; psychiatric and cardiovascular status).
Sleep and appetite: track changes (for example, with a sleep diary and weight log) and report these at each review.
Your specialist may ask you to complete standard rating scales (such as the Adult Self‑Report Scale) to track symptom change during titration.
Schedule 2 status and practical consequences
Lisdexamfetamine is a Schedule 2 controlled drug under the Misuse of Drugs Regulations in the UK. This has practical consequences for prescribing, dispensing, and storage.bucksformulary+3
What changes for you as a patient
Prescription rules: Your prescription must meet controlled‑drug requirements (specific wording, dose form, total quantity in words and figures). Your prescriber and pharmacist follow strict rules on how these prescriptions are written and supplied.
Supply limits: Pharmacists often supply limited quantities at a time and must record supplies in a controlled drugs register. You may notice smaller quantities per prescription compared with non‑controlled medicines.
Storage and safekeeping: You are expected to store your medication securely and not share it. Diversion (giving or selling to others) is illegal and can have serious consequences.
Driving and the law: Lisdexamfetamine is included in drug‑driving regulations. It is an offence to drive if the medicine impairs you, but there is a “statutory defence” if you are taking it as prescribed and it does not affect your driving. You must follow DVLA guidance and tell them if your ADHD or medication affects your driving.
Your specialist and pharmacist should explain these points when you start treatment.
Costs: NHS, private, and shared care
Costs vary depending on whether you are on an NHS pathway, a private prescription, or a shared‑care arrangement. Figures below are typical ranges reported in 2025–2026; exact amounts depend on your nation, pharmacy, and dose.midandsouthessex.ics.nhs+5
NHS pathway (England)
Prescription charge: £9.90 per item in England (free in Scotland, Wales, and Northern Ireland).midandsouthessex.ics.nhs+2
Prepayment certificate (PPC): Around £114.50 per year (or ~£32 for 3 months), which can save money if you need multiple items.midandsouthessex.ics.nhs+1
Clinical care: Assessment, titration, and reviews are NHS‑funded, but waiting times can be long.midandsouthessex.ics.nhs+1
Private pathway (self‑funded)
Assessment and titration: Private adult ADHD assessments commonly cost £600–£1,500+, with titration appointments charged separately.midandsouthessex.
Private prescriptions: You pay the full medicine cost plus a private prescription fee. For lisdexamfetamine, typical monthly costs are often in the range of £80–£200+ depending on dose and pharmacy, plus dispensing fees.midandsouthessex.
Ongoing reviews: Private follow‑ups and prescription admin can add several hundred pounds per year if not transferred to shared care.midandsouthessex.
Shared care (private diagnosis, NHS prescribing)
How it works: A specialist diagnoses and stabilises you, then asks your GP to take over routine prescribing under a shared‑care agreement.
Cost impact: If your GP accepts shared care, you usually pay only the standard NHS prescription charge (£9.90 per item in England) instead of private rates.midandsouthessex.
If GP declines: You may need to remain on private prescriptions or seek another NHS route; some people use patient‑support resources or advocacy to request shared care.
What to do if you are diagnosed but have no prescriber
This situation is unfortunately common, especially with long NHS waiting lists or when GPs are hesitant to prescribe after a private diagnosis.
Typical scenarios
Diagnosed privately, GP refuses shared care: You remain responsible for private prescriptions until shared care is agreed or another NHS route is found. Some clinics offer ongoing private prescribing at a fee; others may discharge you if shared care is declined.midandsouthessex.
NHS diagnosis, but no local prescriber willing to start/maintain: Your specialist service should clarify who will initiate and continue prescribing. In some areas, this is done within the specialist clinic until a GP agrees to shared care.midandsouthessex.
Between jobs or moving areas: If you move or change GP, you may need a new shared‑care agreement. Your specialist should provide a summary letter and treatment plan to support this.
Practical steps you can take
Ask your specialist for a clear written treatment plan (diagnosis, medication, dose, monitoring schedule, and shared‑care request).
Request a shared‑care letter template or clinic letter addressed to your GP, referencing NICE NG87 and local ICB policies.
If your GP declines, ask why and whether concerns are about monitoring, experience, or local policy; sometimes additional information or a trial period helps.
Use patient advocacy (for example, ADHD UK, local ICB complaints processes) if you believe you are being left without a safe prescribing route after diagnosis.
You should not run out of medication abruptly; if you are at risk, contact your prescriber or specialist service urgently to discuss a safe plan.
FAQs
1. What is the usual starting dose of Elvanse for adults in the UK?
For adults, the SmPC recommends 30 mg once daily in the morning as the starting dose, with the option to begin at 20 mg once daily if the clinician feels a lower start is appropriate.
2. How often can the dose be increased?
Dose increases are typically made at approximately weekly intervals, in increments of 10–20 mg, depending on response and tolerability. Many UK protocols describe 20 mg weekly steps for adults once the starting dose is established.
3. What is the maximum dose of Elvanse for adults?
The maximum recommended dose is 70 mg once daily. Doses above 70 mg/day have not been studied in adults and are not recommended.
4. How long does titration usually take?
Titration often takes 4–6 weeks or longer, depending on how quickly you respond, how well you tolerate dose changes, and whether you have comorbidities that require slower titration. NICE recommends regular review during this period, often with weekly contact.
5. What if I get insomnia or loss of appetite?
Insomnia and decreased appetite are very common early on. Strategies include taking the dose early in the morning, avoiding late caffeine, prioritising protein‑rich meals when appetite is better, and discussing dose/formulation adjustments with your prescriber if problems persist.
6. Do I need blood tests or heart tests?
Before starting, your specialist should check your cardiovascular history, blood pressure, and pulse, and monitor these regularly during treatment. Further cardiac tests are arranged if your history or examination suggests underlying heart disease. Routine blood tests are not always required unless there are specific concerns.
7. Can I drive while taking Elvanse?
You must not drive if the medicine affects your ability to drive safely. Lisdexamfetamine is covered by drug‑driving laws; however, there is a statutory defence if you are taking it as prescribed and it does not impair you. You must follow DVLA guidance and declare relevant conditions if required.
8. What happens if I run out of medication?
Do not self‑adjust or borrow from others. Contact your prescriber or specialist service immediately to arrange an urgent prescription or plan. Running out can cause rebound symptoms and distress, and abrupt changes are not recommended.
Book an ADHD Assessment or Transfer Your Prescribing
Stuck between an ADHD diagnosis and a prescriber?
If you’ve been diagnosed (or think you might have ADHD) but can’t access medication, you don’t have to stay stuck.
NHS Right to Choose assessments available in England
Private adult ADHD assessments with clear shared‑care planning
Support with prescribing transfer and GP engagement after diagnosis
Book an ADHD assessment today and take the next step towards a clear diagnosis and a safe, sustainable treatment plan.
If you already have a diagnosis and need help moving your prescribing to a new service or GP, see our dedicated page: ADHD Prescribing Transfer – Focus Gently.
